JHS Svendgaard Laboratories Ltd (JHS) has become PAT positive after 6 years. The Company has been through its share of cyclical business upheavals to emerge stronger. JHS has recovered well after its product portfolio growth with top Indian FMCG brand / company in last 2 years. The company has reported total revenues of Rs.105.48 Cr. up by 5.39%. EBIDTA is up 68% at Rs.12.04 Cr. and the PAT at Rs.21.98 Cr.
JHS is also engaged further in aggressive capacity creation and is investing heavily in the capital equipment(s), almost to the tune of Rs.30 Cr. towards setting up additional manufacturing unit and equipment balancing at our first unit, with the objective of creating a future-ready company by July'2017.
The overall capacity in toothbrushes to increase from 150 million toothbrushes (March 31, 2017) to 250 million toothbrushes (March 31, 2018). For Toothpaste from 90 million toothpaste tubes (March 31, 2017 ) to 175 million toothpaste (July 30, 2017), and from only 3 size tubes to 7 size tubes 18/30/50/80/100/150/200 gms.
The aggressive CAPEX is backed by visibility of business from some of our larger clients including Patanjali and Dabur. Alongwith, JHS own brand, AquaWhite, is scaling distribution and we intend to significantly strengthen the brand franchisee and product positioning in coming months.
Interestingly the Company shall continue to debt-free coupled with strategic equity investors who understands the business and have provided a significant part of the Company's precious growth capital with long term goals in mind.
Shares of JHS SVENDGAARD LABORATORIES LTD. was last trading in BSE at Rs.46 as compared to the previous close of Rs. 46.05. The total number of shares traded during the day was 37009 in over 198 trades.
The stock hit an intraday high of Rs. 48 and intraday low of 44.4. The net turnover during the day was Rs. 1710976.